As the value chains of life sciences and healthcare converge, pharmaceutical companies are pursuing new models of clinical research and integrated care delivery, all in pursuit of a patient-centric future.
By 2026, 65% of life sciences companies plan to modernize their digital infrastructure to support these new capabilities and strengthen their supply chains.
In this InfoBrief, you will:
When you look at your own supply chain and evaluate the visibility you have into the movement of your products, is there transparency all the way from sourcing through manufacturing? From your loading dock to their end destinations? Is achieving this insight even possible?
Discover ways improve supply chain visibility and take action on what you see.